Literature DB >> 178796

Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

L K Curtiss, T S Edgington.   

Abstract

Low density lipoproteins (LDL) containing apolipoprotein B were separated from 15 fresh normal human serum pools by three independent isolation methods including sequential ultracentrifugal flotation, affinity chromatography, and polyanion precipitation. A discrete subpopulation of LDL (LDL-In) was isolated which possessed comparable inhibitory activity for PHA, PWM, and allogenic cell stimulated human lymphocytes in vitro at concentrations of 1 to 10 mug protein/1 x 10(5) lymphocytes/0.25 ml culture. LDL-In was characterized by a mean buoyant density of 1.055 g/ml in KBr, a m.w. of 2 to 3 x 10(6) daltons and a composition of 20 to 25% protein and 75 to 80% lipid with beta electrophoretic mobility. The biologic activity of LDL-In was non-cytotoxic, independent of mitogen concentration, and dependent upon the concentration of serum in the culture assay. The effect was temporally dependent requiring approximately 24 hr for induction of a stable suppressed state. Suppression was reversible with shorter periods of exposure to LDL-In. LDL-In did not inhibit lymphocytes at periods greater than 19 hr after stimulation, suggesting that LDL-In may influence metabolis events associated with the inductive phase of lymphocyte activation by lectins and allogeneic cells. LDL-In was clearly distinguishable from T lymphocyte E rosette inhibitory factor since it did not influence E rosette function of lymphocytes. The physicochemical and biologic properties of LDL-In clearly distinguish this reguloratory lipoprotein from previously described immunoregulatory factors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178796

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Interactions of alpha1-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness.

Authors:  K M Chiu; R F Mortensen; A P Osmand; H Gewurz
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

4.  Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.

Authors:  L K Curtiss; T S Edgington
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

5.  von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.

Authors:  R R Montgomery; T S Zimmerman
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 6.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  Inhibition by human serum of lymphocyte proliferation stimulated by purified protein derivative of tuberculin and bacillus Calmette-Guérin.

Authors:  R Herman-Brand; B M Sultzer
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

Review 8.  Nutrition and autoimmunity: a review.

Authors:  J Homsy; W J Morrow; J A Levy
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

9.  Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes.

Authors:  M L Wilsher; D A Hughes; P L Haslam
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

10.  Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.

Authors:  J A Cuthbert; P E Lipsky
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.